Quarterly pharmacy formulary change notice

Similar documents
Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

Quarterly pharmacy formulary change notice

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

August 2016 Formulary Updates

Aetna Better Health of Florida Supplemental Preferred Drug List

Quarterly pharmacy formulary change

Quarterly Pharmacy Formulary Change Notice

Step Therapy Group. Atypical Antipsychotic Agents

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Quarterly pharmacy formulary change notice

Neighborhood Medicaid Formulary Changes: June 2017

Quarterly pharmacy formulary change notice

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

3 Tier Formulary Additions

WellCare s South Carolina Preferred Drug List Update

Quarterly pharmacy formulary change notice

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

Aetna Better Health FIDA Plan

**CRITERIA UNDER CMS REVIEW**

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Oral Agents. Fml Limits. Available Strengths NF NF

Pharmacy Updates Summary

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Step Therapy Requirements. Effective: 05/01/2018

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

UPDATE Ohana QUEST Integration Medicaid

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Step Therapy Approval Criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Drug Formulary. A healthier you. A healthier community.

Health Partners Medicare Prime 2019 Formulary Changes

AGGRENOX. Products Affected. Details. GRP B2 Last Updated: 09/01/2018. Aggrenox

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Pharmacy Updates Summary

Step Therapy Approval Criteria

Quarterly pharmacy formulary change notice

December 2016 Formulary Updates

2018 Step Therapy FID 18088

Step Therapy Criteria 2019

Nebraska Medicaid Criteria. Abilify Maintena

PDP Classic Formulary Addendum

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 11/01/2018

ANTIDIABETIC AGENTS - MISCELLANEOUS

Aetna Better Health of Illinois Medicaid Formulary Updates

AGGRENOX. Products Affected. Details. First Health Part D Value Plus (PDP) Last Updated: 10/01/2017. Aggrenox

Network Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT NOVEMBER 30, 2010

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Quarterly pharmacy formulary change notice

ANTIDIABETIC AGENTS - MISCELLANEOUS

Antipsychotic Medications Age and Step Therapy

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

SmithRx Standard Formulary Step Therapy List

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Step Therapy Requirements. Effective: 1/1/2019

ADHD STIMULANTS-S(SHC)

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

November 2016 Formulary Updates

CARE N CARE HEALTH PLAN

1, 2014 PHARMACY BENEFIT

National Preferred Formulary Quantity Limits Drug List Helpful Tip: To search for a specific drug, use the find feature (Ctrl + F)

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

Quarterly Pharmacy Formulary Change Notice

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Transcription:

Provider update This is an update about information in the provider manual. For access to the latest provider manual, go online to https://providers.amerigroup.com/fl. Quarterly pharmacy formulary change notice Summary of change: The formulary changes listed in the table below were reviewed and approved at our June 27, 2016, Pharmacy and Therapeutics Committee meeting. What this means to you: Effective November 1, 2016, the changes outlined below apply to all Amerigroup Florida Healthy Kids (FHK) patients. What is the impact of this change? Effective for all patients on November 1, 2016 THERAPEUTIC CLASS MEDICATION REVISED STATUS RESPIRATORY SPACERS PROTON PUMP INHIBITORS ALCOHOL PREP PADS SPACERS: AEROCHAMBER AEROCHAMBER Z-STAT PLUS AEROCHAMBER PLUS EASIVENT E-Z SPACER FLEXICHAMBER INSPIRACHAMBER PANTOPRAZOLE SOD DR 20 MG TAB PANTOPRAZOLE SOD DR 40 MG TAB BY MANUFACTURER: ONE PHARMACEUTICAL PHOENIX HEALTHCARE SPECIALTY MED HOME AID DIAGNOSTICS SIMPLE DIAGNOSTICS SMITH&N/UNITED BOCA PHARMACAL NON-REFERRED POTENTIAL ALTERNATIVES OPTICHAMBER DIAMOND POCKET CHAMBER VORTEX LITEAIRE MICROSPACER MICROCHAMBER BREATHERITE NEXIUM 24HR 20 MG TABLET (OTC) NEXIUM 24HR 22.3 MG CAPSULE (OTC) OMEPRAZOLE MAG DR 20.6 MG CAP (OTC) OMEPRAZOLE DR 20 MG TABLET (OTC) PREVACID 24HR DR 15 MG CAPSULE(OTC) HEARTBURN TREATMNT 24HR 15 MG (OTC) BY MANUFACTURER: MCKESSON DRUG TARGET CORP. RITE AID CORP. WALGREEN CO. LEADER CVS WAL-MART STORES BD DIABETES https://providers.amerigroup.com FLPEC-1212-16 October 2016

LONG-ACTING INJECTABLE ANTIPSYCHOTICS INVEGA SUSTENNA INVEGA TRINZA ABILIFY MAINTENA ER ARISTADA ER PREFERRED WITH PRIOR AUTHORIZATION (PA) REQUIRED LONG-ACTING INJECTABLE ANTIPSYCHOTICS ZYPREXA RELPREVV RISPERDAL CONSTA PREFERRED WITH PA (CURRENT UTILIZERS WILL BE GRANDFATHERED) ALKYLATING CYCLOPHOSPHAMIDE CAPS PREFERRED ALPHA PROTEINASE INHIBITOR ANTICONVULSANTS ANTIDEPRESSANTS ANTIDEPRESSANTS ANTIDIURETIC AND VASOPRESSOR HORMONES ANTIFUNGAL ANTIHYPERTENSIVE ANTIMETABOLITES ANTIMETABOLITES ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS ANTINEOPLASTIC INJECTIONS PROLASTIN C 1;000 MG VIAL BRIVIACT TABLET BRIVIACT 10 MG/ML ORAL SOLN BRIVIACT 50 MG/5 ML VIAL ESCITALOPRAM TABLETS ESCITALOPRAM SOLN FLUOXETINE HCL 60 MG TABLET ADD PA AND QL PREFERRED FLUOXETINE HCL 10 MG CAPSULE FLUOXETINE HCL 20 MG CAPSULE FLUOXETINE HCL 20 MG TABLET DDAVP 0.2 MG TABLET MYCELEX TROCHE NOXAFIL 40 MG/ML SUSPENSION TARKA ER 2-180 MG TABLET NICARDIPINE 30 MG CAPSULE PRINIVIL 5 MG TABLET PRINIVIL 10 MG TABLET PRINIVIL 20 MG TABLET ZESTORETIC 10-12.5 MG METHOTREXATE INJ TABLOID TABLET TREXALL TABLET ADRUCIL VIAL FLUOROURACIL VIAL GEMCITABINE VIAL ZEMBRACE SYMTOUCH ONZETRA XSAIL NASAL SPRAY IMITREX 6 MG/0.5 ML VIAL AVASTIN 100 MG/4 ML VIAL AVASTIN 400 MG/16 ML VIAL LEUPROLIDE 2WK 1 MG/0.2 ML KIT PREFFERED STEP THERAPY (ST) REQUIRED Page 2 of 6

ANTINEOPLASTIC DRUGS ANTINEOPLASTIC DRUGS ANTIPSORIATIC/ ANTISEBORRHEIC ANTIVERTIGO & ANTIEMETIC BARBITURATE COMBINATION CHEMOTHERAPY RESCUE/ANTIDOTE HERCEPTIN 440 MG VIAL INTRON VIALS LEUPROLIDE 2WK 1 MG/0.2 ML KIT LUPRON DEPOT KITS SYNRIBO 3.5 MG/ML VIAL TORISEL 25 MG KIT TRELSTAR SYRINGE VECTIBIX VIAL ZALTRAP VIAL ZOLADEX IMPLANT SYRN SIGNIFOR LAR VIAL SOMATULINE DEPOT FIRMAGON KIT SANDOSTATIN VIALS/AMPULS SANDOSTATIN LAR DEPOT VIALS/KITS TALTZ 80 MG/ML AUTOINJECTOR TALTZ 80 MG/ML SYRINGE EMEND CAPSULE EMEND TRIPACK EMEND 150 MG VIAL 25-325 MG 50 MG-300 MG TABLET 50 MG-325 MG TABLET 50 MG-650 MG CAFFEINE 50 MG-325 MG-40 MG/15 ML SOLUTION CAFFEINE 50 MG-300 MG-40 MG CAPSULE CAFFEINE 50 MG-325 MG-40 MG CAPSULE CAFFEINE 50 MG-325 MG-40 MG TABLET BUTALBITAL-ASPIRIN-CAFFEINE 50 MG-325 MG-40 MG CAPSULE BUTALBITAL-ASPIRIN-CAFFEINE- CODEINE 50 MG-325 MG-40 MG- 30 MG CAPSULE ADD PA AND QL ADD PA AND QL VISTOGARD 10 GRAM PACKET Page 3 of 6

DERMATOLOGICALS GNRH CARAC 0.5% CREAM EFUDEX 5% CREAM TOLAK 4% CREAM FLUOROURACIL 5% TOP SOLUTION FLUOROURACIL 2% TOPICAL SOLN FLUOROPLEX 1% CREAM ALDARA 5% CREAM PICATO 0.015% GEL PICATO 0.05% GEL SOLARAZE 3% GEL LUPANETA PACK 3.75/5 MG LUPANETA PACK 11.25/5 MG LUPRON DEPOT PED 30 MG LUPRON DEPOT PED 11.25 OR 15 MG LUPRON DEPOT 7.5 MG LUPRON DEPOT 11.25 MG, 22.5 MG LUPRON DEPOT 30 MG SUPPRELIN LA SYNAREL GROWTH HORMONE RECEPTOR ANTAGONISTS SOMAVERT 10MG,15 MG, 20MG, 25MG, 30MG HIV INTELENCE PA REMOVED LAXATIVES AND CATHARTICS MIRALAX MITOTIC INHIBITORS NASAL STEROIDS NEUROLOGICAL THERAPY NON-SEDATING ANTIHISTAMINES (NSA) CHEMET DESFERAL IXEMPRA 15 MG KIT IXEMPRA 45 MG KIT RHINOCORT ALLERGY (OTC) NASONEX/ MOMETASONE GRALISE ER 300MG GRALISE ER 600 MG HORIZANT 300MG, 600 MG CLARINEX 0.5 MG/ML (2.5 MG/5) CHILD'S CLARITIN 5 MG TAB CHEW CLARITIN 5 MG REDITABS PA REQUIRED FEXOFENADINE HCL 60 MG TABLET (OTC) FEXOFENADINE HCL 180 MG TABLET (OTC) LORATADINE ALLERGY 5 MG/5 ML (OTC) LORATADINE 10 MG ODT (OTC) NSAID VIVLODEX CAPSULE Page 4 of 6

OPHTHALMIC ANGIOGENESIS INHIBITORS LUCENTIS 0.5 MG VIAL LUCENTIS 0.3 MG VIAL OPIOID DEPENDANCE EVZIO OPIOID DEPENDANCE NARCAN NASAL SPRAY NALOXONE INJECTION OSTEOPOROSIS THERAPY ALENDRONATE SOD 70 MG/75 ML PREFERRED OSTEOPOROSIS THERAPY FORTEO 600 MCG/2.4 ML PEN INJ SKELETAL MUSCLE RELAXANTS AMRIX 30MG METHOCARBAMOL 750 MG TOPICAL ANTI- INFLAMMATORY- NSAIDS FLECTOR PATCH PENNSAID 1.5% PENNSAID 2% VOLTAREN GEL PAH TYVASO INHALATION WITH PA PAH ATROVENT HFA ATROVENT SOLUTION PRENATAL VITAMINS ENBRACE HR FOCALGIN 90 DHA COMBO PACK; FOCALGIN CA COMBO PACK NIVA-PLUS OB COMPLETE GOLD PREFERA-OB PLUS DHA COMBO PACK PROVIDA DHA TRISTART DHA VITAFOL FE + DOCUSATE COMBO PACK PROTON PUMP INHIBITORS DEXILANT SOLUTAB RH IMMUNE GLOBULIN RHEUMATOLOGICAL MICRHOGAM ULTRA-FILTD PLUS SYR RHOGAM ULTRA-FILTERED WINRHO SDF HYPERRHO S-D RHOPHYLAC 300 MCG/2 ML SYRINGE SAVELLA TITRATION PACK SAVELLA TABLET WITH PA RHEUMATOLOGICAL KINERET 100 MG/0.67 ML SYRINGE Page 5 of 6

RHEUMATOLOGICAL UTI PROPHYLAXIS UTI PROPHYLAXIS VACCINES & IMMUNOLOGICALS XELJANZ XR TABLET ADD PA AND QL NITROFURANTOIN MCR 25 MG CAP NITROFURANTOIN 25 MG/5 ML SUSP PREFERRED NITROFURANTOIN MCR 25 MG, 50MG AND 100 MG CAP NITROFURANTOIN MONO-MCR 100 MG CYTOGAM 2.5 GM/50 ML VIAL What action do I need to take? Please review these changes and work with your Amerigroup patients to transition them to formulary alternatives. If you determine preferred formulary alternatives are not clinically appropriate for specific patients, you will need to obtain prior authorization (PA) to continue coverage beyond the applicable effective date. What if I need assistance? We recognize the unique aspects of patients cases. If, for medical reasons, your Amerigroup patient cannot be converted to a formulary alternative, call our Pharmacy department at 1-800- 454-3730 and follow the voice prompts for pharmacy PA. You can find the preferred drug list on our provider website at https://providers.amerigroup.com/fl. If you need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-800-454-3730. Page 6 of 6